-
Product Insights
Primary Sjogren’s Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Primary Sjogren's Syndrome - Drugs In Development, 2023’, provides an overview of the Primary Sjogren's Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Primary Sjogren's Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Pulmonary Sarcoidosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Pulmonary Sarcoidosis - Drugs In Development, 2023’, provides an overview of the Pulmonary Sarcoidosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pulmonary Sarcoidosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Pemphigus – Drugs In Development, 2023
Global Markets Direct’s, ‘Pemphigus - Drugs In Development, 2023’, provides an overview of the Pemphigus pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pemphigus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Sarcoidosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Sarcoidosis - Drugs In Development, 2023’, provides an overview of the Sarcoidosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Sarcoidosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Cutaneous Lupus Erythematosus – Drugs In Development, 2023
Global Markets Direct’s, ‘Cutaneous Lupus Erythematosus - Drugs In Development, 2023’, provides an overview of the Cutaneous Lupus Erythematosus pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cutaneous Lupus Erythematosus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Hematopoietic Stem Cell Transplantation – Drugs In Development, 2023
Global Markets Direct’s, ‘Hematopoietic Stem Cell Transplantation - Drugs In Development, 2023’, provides an overview of the Hematopoietic Stem Cell Transplantation pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hematopoietic Stem Cell Transplantation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Anaphylaxis – Drugs In Development, 2023
Global Markets Direct’s, ‘Anaphylaxis - Drugs In Development, 2023’, provides an overview of the Anaphylaxis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anaphylaxis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) – Drugs In Development, 2023
Global Markets Direct’s, ‘Granulomatosis with Polyangiitis (Wegener's Granulomatosis) - Drugs In Development, 2023’, provides an overview of the Granulomatosis with Polyangiitis (Wegener's Granulomatosis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Granulomatosis with Polyangiitis (Wegener's Granulomatosis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Lung Transplant Rejection – Drugs In Development, 2023
Global Markets Direct’s, ‘Lung Transplant Rejection - Drugs In Development, 2023’, provides an overview of the Lung Transplant Rejection pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lung Transplant Rejection, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) – Drugs In Development, 2023
Global Markets Direct’s, ‘Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) - Drugs In Development, 2023’, provides an overview of the Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers...